Commentary: Surgical Treatment for Atrial Fibrillation at the Time of Cardiac Surgery: Just Do It

      Concomitant surgical ablation or left atrial appendage occlusion at the time of cardiac surgery should be performed in nearly all patients with atrial fibrillation to improve long-term outcomes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Pyo W.K.
        • Kim H.J.
        • Kim J.B.
        • et al.
        Does surgical ablation for atrial fibrillation benefit patients undergoing bioprosthetic valve replacement?.
        Semin Thorac Cardiovasc Surg. 2022; 34: 906-915
        • Musharbash F.N.
        • Schil M.R.
        • Sinn L.A.
        • et al.
        Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery.
        J Thorac Cardiovasc Surg. 2018; 155: 159-170
        • Hodges K.
        • Tang A.
        • Rivas C.G.
        • et al.
        Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach.
        J Card Surg. 2020; 35: 2957-2964
        • Sankaranarayanan R.
        • Kirkwood G.
        • Visweswariah R.
        • Fox D.J.
        How does chronic atrial fibrillation influence mortality in the modern treatment era?.
        Curr Cardiol Rev. 2015; 11: 190-198
        • Whitlock R.P.
        • Belley-Cote E.P.
        • Paparella D.
        • et al.
        Left atrial appendage occlusion during cardiac surgery to prevent stroke.
        N Engl J Med. 2021; 384: 2081-2091

      Linked Article

      • Does Surgical Ablation of Atrial Fibrillation Benefit Patients Undergoing Bioprosthetic Valve Replacement?
        Seminars in Thoracic and Cardiovascular SurgeryVol. 34Issue 3
        • Preview
          The benefit of avoiding lifelong anticoagulation therapy in patients with bioprosthetic heart valve implantation may potentially be offset by atrial fibrillation (AF); however, clinical impact of surgical AF ablation in such patients remains controversial. We enrolled 426 patients (aged 72.0 ± 7.8 years) with AF who underwent left-side valve replacement with bioprostheses between 2001 and 2018. Of these, 297 underwent concomitant surgical ablation (ablation group) and 129 underwent valve replacement alone (non-ablation group).
        • Full-Text
        • PDF